Efavirenz and Nevirapine Interactions with Rifampicin: Resolving the Dilemmas?

被引:8
作者
Lalloo, Umesh G. [1 ]
机构
[1] Univ KwaZulu Natal, Nelson R Mandela Sch Med, ZA-4013 Congella, South Africa
关键词
HIV-INFECTED PATIENTS; RECEIVING RIFAMPICIN; TUBERCULOSIS; PHARMACOKINETICS; MOXIFLOXACIN;
D O I
10.1086/599115
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1760 / 1762
页数:3
相关论文
共 17 条
[1]  
[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603
[2]  
[Anonymous], 2008, Global tuberculosis control - surveillance, planning, financing
[3]   Development of Phenotypic HIV-1 Drug Resistance After Exposure to Single-Dose Nevirapine [J].
Basson, Adriaan E. ;
Ntsala, Matshediso ;
Martinson, Neil ;
Tlale, Emily ;
Corrigan, Gary E. ;
Shao, Xingwu ;
Gray, Glenda ;
McIntyre, Janles ;
Puren, Adrian ;
Morris, Lynn .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 49 (05) :538-543
[4]   Treatment strategies for HIV-infected patients with tuberculosis: Ongoing and planned clinical trials [J].
Blanc, Francois-Xavier ;
Havlir, Diane V. ;
Onyebujoh, Philip C. ;
Thim, Sok ;
Goldfeld, Anne E. ;
Delfraissy, Jean-Francois .
JOURNAL OF INFECTIOUS DISEASES, 2007, 196 :S46-S51
[5]   Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins [J].
Bonora, S. ;
Mondo, A. ;
Trentini, L. ;
Calcagno, A. ;
Lucchini, A. ;
Di Perri, G. .
JOURNAL OF INFECTION, 2008, 57 (01) :78-81
[6]   Pharmacokinetic study of the interaction between rifampin and delavirdine mesylate [J].
Borin, MT ;
Chambers, JH ;
Carel, BJ ;
Gagnon, S ;
Freimuth, WW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (05) :544-553
[7]   Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis [J].
Burman, William J. ;
Goldberg, Stefan ;
Johnson, John L. ;
Muzanye, Grace ;
Eagle, Melissa ;
Mosher, Ann W. ;
Choudhri, Shurjeel ;
Daley, Charles L. ;
Munsiff, Sonal S. ;
Zhao, Zhen ;
Vernon, Andrew ;
Chaisson, Richard E. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (03) :331-338
[8]  
Centers for disease control and prevention, 2008, MAN DRUG INT TREATM
[9]   Etravirine [J].
Deeks, Emma D. ;
Keating, Gillian M. .
DRUGS, 2008, 68 (16) :2357-2372
[10]   Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV [J].
Friedland, Gerald ;
Khoo, Saye ;
Jack, Christopher ;
Lalloo, Umesh .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (06) :1299-1302